Clinical Trial Update: PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban [Phase 3]

View source ↗

Summary

Phase 3 trial PROACT Xa evaluating whether patients with On-X aortic valves can be safely maintained on apixaban; the study was terminated with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease
• Aortic Valve Failure
• Aortic Valve Stenosis

Drugs mentioned

• Apixaban (apixaban)

Snippet

Sponsor: Artivion Inc. | Conditions: Aortic Valve Disease, Aortic Valve Stenosis | Phase 3 | Status: TERMINATED | Results posted: 2024-03-20